Edges in Network
Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | NFAT5 |
Upstream (Parents) |
---|
(<<) SPEN → NFAT5 |
(<<) MLL → NFAT5 |
Downstream (Children) |
---|
NFAT5 → FOXQ1 (>>) |
NFAT5 → WNT5A (>>) |
NFAT5 → ZNF207 (>>) |
NFAT5 → NR1D2 (>>) |
NFAT5 → DLX6 (>>) |
NFAT5 → ZNF83 (>>) |
NFAT5 → ZBTB38 (>>) |
NFAT5 → TULP4 (>>) |
NFAT5 → GAS7 (>>) |
NFAT5 → MLLT10 (>>) |
NFAT5 → TCF4 (>>) |
NFAT5 → C5orf41 (>>) |
NFAT5 → PROX1 (>>) |
NFAT5 → KDM5A (>>) |
NFAT5 → MGA (>>) |
NFAT5 → ZNF397 (>>) |
NFAT5 → MSRB2 (>>) |
NFAT5 → CTNNB1 (>>) |
NFAT5 → ZFP90 (>>) |
NFAT5 → ZNF148 (>>) |
NFAT5 → UBN1 (>>) |
NFAT5 → SLC2A4RG (>>) |
NFAT5 → GATAD1 (>>) |
NFAT5 → TCF7L2 (>>) |
NFAT5 → TFAM (>>) |
NFAT5 → ATF6 (>>) |
NFAT5 → MEF2A (>>) |
NFAT5 → KLF7 (>>) |
NFAT5 → SMAD5 (>>) |
NFAT5 → PBX3 (>>) |
NFAT5 → CBL (>>) |